ES8606874A1 - Metodo de preparacion de compuestos espiroamidoamino anti- hipertensivos - Google Patents

Metodo de preparacion de compuestos espiroamidoamino anti- hipertensivos

Info

Publication number
ES8606874A1
ES8606874A1 ES541395A ES541395A ES8606874A1 ES 8606874 A1 ES8606874 A1 ES 8606874A1 ES 541395 A ES541395 A ES 541395A ES 541395 A ES541395 A ES 541395A ES 8606874 A1 ES8606874 A1 ES 8606874A1
Authority
ES
Spain
Prior art keywords
compounds
amidoamino
antihypertensive
spiro
substitutents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES541395A
Other languages
English (en)
Other versions
ES541395A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pharmaceutical Corp
Original Assignee
USV Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pharmaceutical Corp filed Critical USV Pharmaceutical Corp
Publication of ES541395A0 publication Critical patent/ES541395A0/es
Publication of ES8606874A1 publication Critical patent/ES8606874A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/30—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hydrocarbon radicals, substituted by hetero atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/80—Antihypertensive peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

METODO DE PREPARACION DE COMPUESTOS ESPIROAMIDOAMINOS DE FORMULA (IV). CONSISTENTES EN HACER REACCIONAR UN COMPUESTO (I) CON UN COMPUESTO (II), Y POSTERIORMENTE TRATAR EL COMPUESTO OBTENIDO CON OTRO DE FORMULA (III) PARA ASI LLEGAR A LA SINTESIS DE UN COMPUESTO DE FORMULA GENERAL (IV). SE UTILIZAN AGENTES DE ACOPLAMIENTO USADOS EN LAS TECNICAS CONVENCIONALES DE UNION DE PEPTIDOS TALES COMO DCC (N,N-DICICLOHEXILCARBODIIMIDA) O CDI (N,N-CARBOCILDIIMIDAZOL). ANTIHIPERTENSIVO.
ES541395A 1984-03-02 1985-03-01 Metodo de preparacion de compuestos espiroamidoamino anti- hipertensivos Expired ES8606874A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/585,769 US4556652A (en) 1984-03-02 1984-03-02 Antihypertensive spiro-amidoamino compounds

Publications (2)

Publication Number Publication Date
ES541395A0 ES541395A0 (es) 1986-05-16
ES8606874A1 true ES8606874A1 (es) 1986-05-16

Family

ID=24342882

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541395A Expired ES8606874A1 (es) 1984-03-02 1985-03-01 Metodo de preparacion de compuestos espiroamidoamino anti- hipertensivos

Country Status (8)

Country Link
US (1) US4556652A (es)
JP (1) JPS60215679A (es)
AU (1) AU579352B2 (es)
DE (1) DE3507576A1 (es)
ES (1) ES8606874A1 (es)
GB (1) GB2155015B (es)
IT (1) IT1183699B (es)
ZA (1) ZA851617B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4555508A (en) * 1984-03-02 1985-11-26 Usv Pharmaceutical Corp. Antihypertensive spiro-cyclic compounds
JPS6248655A (ja) * 1985-08-27 1987-03-03 Kanegafuchi Chem Ind Co Ltd Ｎ−〔１（ｓ）−エトキシカルボニル−３−フエニルプロピル〕−ｌ−アラニルクロリド無機酸塩及びその製造法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050800B2 (en) * 1980-10-23 1995-06-07 Schering Corporation Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
US4555508A (en) * 1984-03-02 1985-11-26 Usv Pharmaceutical Corp. Antihypertensive spiro-cyclic compounds

Also Published As

Publication number Publication date
DE3507576A1 (de) 1985-09-05
ES541395A0 (es) 1986-05-16
US4556652A (en) 1985-12-03
AU3947085A (en) 1985-09-05
IT1183699B (it) 1987-10-22
IT8519719A0 (it) 1985-03-01
ZA851617B (en) 1985-10-30
GB2155015B (en) 1987-07-29
GB2155015A (en) 1985-09-18
AU579352B2 (en) 1988-11-24
JPS60215679A (ja) 1985-10-29
GB8505509D0 (en) 1985-04-03

Similar Documents

Publication Publication Date Title
NO167240C (no) Feste med flere frihetsgrader.
FI840547A7 (fi) Uudet farmakologisesti aktiiviset yhdisteet.
ES554125A0 (es) Procedimiento de preparar hidroxamatos farmaceuticamente activos.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
EP0177940A3 (en) Hydrazine derivatives and their use
AU5300386A (en) Pharmaceutically active podophyllotoxins
ES8507540A1 (es) Un procedimiento para preparar indeno-piridazinonas sustituidas.
DE3784545D1 (de) Filmzufuehrvorrichtung.
AU560971B2 (en) 5-piperazinyl-2,4-pyrimidinediamine derivatives
AU603591B2 (en) 1,4-benzodiazepines
IT1212122B (it) Tamponi auricolari afonizzanti.
ES8602021A1 (es) Procedimiento de preparar compuestos espirociclicos antihi- pertensivos
EP0121830A3 (en) Substituted dipeptides as antihypertensives
ES8609364A1 (es) Procedimiento de preparar derivados antihipertensivos
PH30773A (en) Novel substituted thienopyrans antihypertensive agents.
AU1161583A (en) N,n-disubstituted azolecarboxamides
FI865244A0 (fi) Foerfarande foer framstaellning av optiskt aktiva 2-klor-12-(3-dimetylamino-2-metylpropyl)-12h-dibenzo-/d,g//1,3,6/ dioxazociner.
IE812399L (en) Benzodioxines
AU4004085A (en) 3-mercapto-1,2,4-triazacycloalkadiene derivatives
NO862887D0 (no) Fremgangsmaate for bekjempelse av mikroorganismer.
IT8321255A0 (it) Composti dotati di attivita'sedativa e tranquillante, procedimenti per prepararli e composizioni che li contengono.
AU1974283A (en) 2,3-dihydro-2,2-dimethyl-benzofuran derivatives
EP0114389A3 (en) Substituted arylglyoxal derivatives
SU1132513A1 (ru) 2-метиламино-4-оксо-3,6,6-триметил-5,6-дигидро-8н-пирано[4′,3′ : 4,5]тиено[2,3-d]пиримидин или его соли, обладающие противосудорожной активностью
SU1055108A1 (ru) 5,6-диоксим-2-п-метоксифенацилтетрагидро- 3,4,5,6-пиразинон-3, обладающий противовоспалительной активностью

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981001